Suchergebnisse - "Favalli, Ennio Giulio"

PubPharm (18)

1

Personalized medicine in rheumatoid arthritis : How immunogenicity impacts use of TNF inhibitors

enthalten in: Autoimmunity reviews | 2020

von Bodio, C. | Grossi, C. | Pregnolato, F. | +16

2

Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs

enthalten in: Joint bone spine | 2018

von Atzeni, F. | Carletto, A. | Foti, R. | +15

3

Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis : a cost-consequence analysis in the Italian setting

enthalten in: Clinical and experimental rheumatology | 2018

von Iannazzo, S. | Benucci, M. | Favalli, E.

4

Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences

enthalten in: Clinical rheumatology | 2017

von Favalli, E. | Pontikaki, I. | Becciolini, A. | +8

5

A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases : focus on interchangeability

enthalten in: Drug design, development and therapy | 2017

von Becciolini, A. | Raimondo, M. | Crotti, C. | +3

6

Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis : Real-Life Data From a Local Registry

enthalten in: Arthritis care & research | 2016

von Favalli, E. | Pregnolato, F. | Biggioggero, M. | +4

7

Ten-year drug survival of anti-TNF agents in the treatment of inflammatory arthritides

enthalten in: Drug development research | 2014

von Biggioggero, M. | Favalli, E.

8

The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment : data from a systematic review and meta-analysis

enthalten in: Seminars in arthritis and rheumatism | 2014

von Favalli, E. | Pregnolato, F. | Biggioggero, M. | +1

9

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis : an approach to a personalized medicine

enthalten in: Arthritis care & research | 2013

von Gremese, E. | Carletto, A. | Padovan, M. | +14

10

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis : comparison of adalimumab, etanercept and infliximab in the GISEA registry

enthalten in: Autoimmunity reviews | 2012

von Atzeni, F. | Sarzi-Puttini, P. | Botsios, C. | +24